Michel Lagarde - 02 Dec 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Executive Vice President & COO
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Issuer symbol
TMO
Transactions as of
02 Dec 2025
Net transactions value
-$25,188,446
Form type
4
Filing time
04 Dec 2025, 16:46:00 UTC
Previous filing
14 Nov 2025
Next filing
05 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lagarde Michel Executive Vice President & COO 168 THIRD AVENUE, WALTHAM /s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde 04 Dec 2025 0001518973

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $3,786,120 +36,000 +153% $105.17 59,480 02 Dec 2025 Direct
transaction TMO Common Stock Sale $17,457,600 -30,000 -50% $581.92 29,480 02 Dec 2025 Direct F1
transaction TMO Common Stock Options Exercise $7,151,560 +68,000 +231% $105.17 97,480 03 Dec 2025 Direct
transaction TMO Common Stock Sale $17,195,985 -29,479 -30% $583.33 68,001 03 Dec 2025 Direct F2
transaction TMO Common Stock Sale $1,472,541 -2,521 -3.7% $584.11 65,480 03 Dec 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -36,000 -29% $0.000000 86,637 02 Dec 2025 Common Stock 36,000 $105.17 Direct F4
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -68,000 -78% $0.000000 18,637 03 Dec 2025 Common Stock 68,000 $105.17 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $581.90 to $582.33, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $583.03 to $583.96, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $584.00 to $584.533, inclusive.
F4 The option vested in two equal installments on August 29, 2017 and 2020.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney